Annualised growth rate of 7.7%
Industry Voice: Biotech companies are increasingly pioneering groundbreaking therapies for diseases with high unmet medical need. Investing in these innovation leaders is a hallmark of BB Biotech'sinvestment philosophy.
Asset and wealth manager trading updates
Two co-managers appointed